Acute Myeloid Leukemia (AML)

Cardiovascular Concerns after HCT from the 2024 Los Angeles Patient and Family Conference

Topic(s)

Bone Marrow Transplant

Presenter(s)

June-Wha Rhee, MD

Dr. June-Wha Rhee describes the potential for cardiovascular complications after HCT, or hematopoietic stem cell transplantation, in this session from the 2024 Los Angeles Patient and Family Conference.

Clinical Trials

Read more about Clinical Trials

Clinical research Clinical research: A type of research that involves individual persons or a group of people.

Hydroxyurea

Read more about Hydroxyurea

Heparin

Read more about Heparin

Enoxaparin

Read more about Enoxaparin

Deferoxamine

Read more about Deferoxamine

Deferoxamine Deferoxamine: Deferoxamine is an iron-binding agent that belongs to a class of drugs known as heavy metal antagonists.

Daunorubicin

Read more about Daunorubicin

Cytarabine (ara-C)

Read more about Cytarabine (ara-C)

Prednisone

Read more about Prednisone

Prednisone Prednisone: Prednisone a man-made version of a hormone produced naturally by the adrenal gland that can help reduce inflammation and stop allergic responses.

Bone Marrow Transplant

Read more about Bone Marrow Transplant

A bone marrow transplant (BMT) bone marrow transplant (BMT): A procedure where bone marrow stem cells are c

Subscribe to Acute Myeloid Leukemia (AML)

AAMDSIF Awareness Week

Acute Myeloid Leukemia (AML)

Cardiovascular Concerns after HCT from the 2024 Los Angeles Patient and Family Conference

Clinical Trials

Hydroxyurea

Heparin

Enoxaparin

Deferoxamine

Daunorubicin

Cytarabine (ara-C)

Prednisone

Bone Marrow Transplant

Website Feedback